Denavir (Penciclovir)

DENAVIR topical is in the FDA pregnancy category B. This means that it is unlikely to harm an unborn baby. Do not use DENAVIR topical during pregnancy without first talking to your doctor.

It is not known whether DENAVIR topical passes into breast milk. Do not use DENAVIR topical if you are breast-feeding a baby without first talking to your doctor.

Serious side effects have not been reported with the use of DENAVIR topical.

Other less serious side effects may be more likely to occur. Continue to use DENIVIR topical and talk to your doctor if you experience:

• headache;
• local numbness or tingling where the cream is applied;
• changes in taste;
• rash; or
• irritation at the application site.

There are no restrictions on food, beverages, or activity during treatment with DENAVIR topical, unless otherwise directed by your doctor.  Do not use other topical medications to treat the same area at them same time as DENAVIR topical, unless otherwise directed by your doctor.

DENAVIR topical should be applied to cold sore lesions every 2 hours while awake for a period of four days, unless otherwise directed by your doctor.